Healthcare
Live Price
Offline$77.29
-0.43% today
1Y Change
+4.03%
Window
Jun 30, 2025 → Jun 25, 2026
Coverage: 248 bars · Jun 30, 2025 → Jun 25, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Haemonetics Corporation (HAE) is a Healthcare stock with a market cap of $2.79B and listed on NYSE. The stock last traded around $77.29 and up 4.0% across the available one-year price window (Jun 30, 2025 → Jun 25, 2026). Baseline metrics include revenue growth of +4.0%, EPS growth of +42.7%, a dividend yield of 0.0%. What stands out right now is revenue +4.0%, EPS +42.7%, free cash flow +23.4% with operating margin 19.2% and ROIC 8.7%. Valuation is more restrained than many high-expectation growth names at P/E 16.0 and price/sales 2.1. Stock Foundry combines HAE price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
Relative Read
HAE is 14.81 pts behind over the shared 1Y window.
HAE had 30.93 pts deeper max drawdown than SPY.
HAE beat SPY in 0 of 2 calendar years shown and trailed in 2.
HAE
+4.03%
Normalized return
SPY
+18.85%
S&P 500
Excess Return
-14.81 pts
Relative to SPY
HAE Max Drawdown
-40.06%
Trailing 1Y
SPY Max Drawdown
-9.13%
Trailing 1Y
Uses the longest available daily history for HAE and SPY.
| Year | HAE | SPY | Excess | Leader |
|---|---|---|---|---|
| 2026 | -2.95% | +6.71% | -9.66 pts | SPY |
| 2025 | +8.54% | +11.19% | -2.66 pts | SPY |
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.